30
Participants
Start Date
April 19, 2023
Primary Completion Date
March 10, 2024
Study Completion Date
March 10, 2025
Prolgolimab
Prolgolimab monotherapy 1 mg/kg IV every 2 weeks up to a maximum of 24 cycles
Combination with prolgolimab and bendamustine
Prolgolimab 1 mg/kg IV D1,15; Bendamustine 90 mg/m2 IV D1,2, 28-day cycle, maximum of 3 cycles;
RECRUITING
St. Petersburg State Pavlov Medical University, Saint Petersburg
RECRUITING
N.N. Petrov National Medical Research Center of Oncology, Saint Petersburg
N.N. Petrov National Medical Research Center of Oncology
OTHER
St. Petersburg State Pavlov Medical University
OTHER